"Omeprazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Descriptor ID |
D009853
|
| MeSH Number(s) |
D02.886.640.074.500 D03.383.725.024.500 D03.633.100.103.034.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Omeprazole".
Below are MeSH descriptors whose meaning is more specific than "Omeprazole".
This graph shows the total number of publications written about "Omeprazole" by people in this website by year, and whether "Omeprazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 4 | 0 | 4 |
| 1996 | 6 | 2 | 8 |
| 1997 | 4 | 1 | 5 |
| 1998 | 5 | 0 | 5 |
| 1999 | 5 | 1 | 6 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 3 | 1 | 4 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Omeprazole" by people in Profiles.
-
Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019 10 17; 381(16):1513-1523.
-
Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA. 2016 May 17; 315(19):2104-12.
-
Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
-
Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors. J Clin Gastroenterol. 2008 Apr; 42(4):368-72.
-
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol. 2006 Sep; 101(9):1972-8; quiz 2169.
-
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1207-14.
-
Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
-
Extraesophageal manifestations of GERD: diagnosis and therapy. Drugs Today (Barc). 2005 Jul; 41 Suppl B:19-26.
-
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
-
The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther. 2004 Feb 15; 19(4):443-8.